+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID04354064

Using Circulating Tumor DNA to Monitor Early Treatment Response in Solid Tumor Cancers

Led by Washington University School of Medicine · Updated on 2026-02-20

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of circulating tumor DNA ctDNA to detect early treatment responses and disease recurrence in patients with various solid tumors and healthy volunteers. The study aims to enhance cancer diagnosis, treatment, surveillance, and prognosis by integrating ctDNA into clinical practice, potentially guiding personalized medical decisions. This translational research could lead to future interventional trials focusing on early therapeutic escalation using ctDNA molecular residual disease detection. Participants include healthy donors and patients with cancers such as prostate, head and neck, esophageal, genitourinary, sarcoma, breast, colon, gastrointestinal, lung, skin, and melanoma. The study involves collecting blood and urine samples as often as every two months, up to 24 times, to generate reference data and compare patient data for molecular residual disease. Samples are also obtained from various tissue and plasma repositories and banking studies related to these cancers. During the study, participants will provide biological samples for analysis, which will be used to monitor outcomes including freedom from progression, event-free survival, disease-specific survival, overall survival, pathologic complete response rate, locoregional failure, and distant-metastasis-free survival. The study is expected to continue for approximately 6.5 years, with ongoing sample collection and outcome assessment under the oversight of Washington University School of Medicine.

CONDITIONS

Brief Title

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Research Team

M

Melissa Reimers, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here